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Background: Peru is characterized by high cervical cancer incidence and mortality rates. The 
country also experiences significant gaps in quality cervical cancer screening coverage for the 
population.
Objective: This descriptive mixed methods study conducted in Cusco, Peru, aimed to assess 
the attitudes and perceptions of medical staff, health care workers, and patients toward a cervi-
cal cancer screening program that included both clinic-based and community outreach services 
conducted by a nongovernmental organization clinic (CerviCusco). The study also explored 
patient knowledge and attitudes around cervical cancer and about the human papillomavirus 
(HPV) to inform patient education efforts.
Methods: The study employed structured interviews with key informants (n=16) primarily 
from CerviCusco, which provides cervical cancer prevention, screening, diagnosis and treat-
ment services, and surveys with a sample of patients (n=30) receiving services at the clinic and 
at screening campaigns.
Results: The majority of key informant medical staff participants felt that the general public had 
a very negative view of government health services. One theme running throughout the interviews 
was the perception that the general population lacked a culture of preventive health care and 
would wait until symptoms were severe before seeking treatment. Regarding services that were 
received by patients at CerviCusco, the participants responded that the prices were reasonable 
and more affordable than some private clinics. Patients attending the rural health campaigns 
liked that the services were free and of good quality.
Conclusion: CerviCusco has demonstrated its capacity to provide screening outreach cam-
paigns to populations who had not previously had access to liquid-based cytology services. 
The finding that patients had generally low levels of knowledge about cervical cancer and the 
HPV vaccine prompted the development of culturally and linguistically appropriate educational 
and promotional materials to improve the educational component of the periodic campaigns 
conducted primarily in rural areas of Andean Peru.
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Introduction
Despite global advances in the prevention of cervical cancer with the introduction of the 
human papillomavirus (HPV) vaccine and attempts to deliver comprehensive cervical 
cancer screening programs, women from developing countries in Latin America con-
tinue to experience higher rates of cervical cancer morbidity and mortality than those 
in developed countries. Cervical cancer is the second most common cancer among 
women worldwide; however, it can be prevented when premalignant changes of the 
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cervix are detected early and treated appropriately. Peru 
is characterized by high incidence of cervical cancer and 
mortality rates, with an age-standardized incidence rate of 
32.7/100,000 population and a mortality rate of 12.0/100,000 
population.1 In comparison, according to GLOBOCAN 2012, 
the overall mortality rate in South America is 8.6/100,000. 
In some other South American countries, the mortality rates 
are lower than that of Peru; for example, the mortality rate in 
Brazil is 7.3/100,000 population, Chile 6.0/100,000 popula-
tion, and Colombia 8.0/100,000 population.2 In Peru, there 
were an estimated 4,635 new cervical cancer cases and 1,715 
cervical cancer deaths in 2012, second only to stomach cancer 
in women; moreover, the disease was the leading cause of 
cancer deaths in women between 15 and 44 years of age.1
Early detection of cervical neoplasia with Pap tests is the 
optimal strategy to reduce the incidence and mortality rates 
in Peru, because in low resource settings, the cost of the 
HPV vaccine is too expensive for most Peruvians.3 Because 
of the relatively high costs of the Pap test and variable 
quality of samples, several prevention campaigns in Peru 
have employed the lower-cost, visual inspection with acetic 
acid (VIA) screening method followed by cryotherapy for 
cervical lesions.4,5 A successful Pap testing program requires 
an investment in training for cytotechnologists and cyto-
pathologists, as well as capacity building for essential sup-
plies and quality laboratory equipment. Moreover, because 
regular cervical cancer screening using Pap tests requires 
resources and a quality control program for both screening 
and follow-up, capacity for delivering cancer education, and 
regular contact with health care providers who recommend 
screening, low-resource countries face challenges in reaching 
a large proportion of population, especially in rural areas.6
Peru’s cervical cancer screening guidelines are targeted 
at women between 30 and 50 years and include annual Pap 
tests, VIA every 2 years, and the HPV DNA test every 
5 years.7 Rough estimates place screening coverage at 51% 
of the eligible population, but there are reported variations 
in rural (42%) and urban (57%) areas.1,8 One large study 
carried out in 20 of the most populous cities reported Pap 
test coverage to be ~31% among young women (18–29 years 
old).3 The study found regional differences, with Andean 
women significantly less likely to be screened than women 
from the coast.
In low-resource settings such as Cusco, Peru, and the sur-
rounding rural communities in the Peruvian Andes, structural 
barriers to cervical cancer screening include lack of access 
to health care, shortage of quality facilities and laboratories 
(outside of Lima, few facilities can perform cone biopsies or 
colposcopies), few trained personnel, distance to health care 
facilities, irregular hours of operation, long waiting times, 
and lack of affordable options for follow-up care.9 Individual 
and cultural barriers include lack of preventive health-seeking 
behaviors, low exposure to biomedical procedures, poor 
knowledge of cervical cancer, language barriers (for non-
Spanish speakers), negative views of health care providers, 
lack of spousal support for health care seeking, anxiety and 
fear over potential positive cancer diagnoses, shortage of 
female providers, and modesty regarding exposure of one’s 
body.3,5,10 Facilitators to screening include peace of mind after 
receiving negative results, sense of control and empowerment 
over one’s own health, support from friends and family, and 
reassurance against the detection of other sexually transmit-
ted infections or vaginal infections.10
In terms of HPV vaccination, there was a demonstration 
project conducted by the Peru Ministry of Health (MINSA) 
in 2008 for school-based vaccination to girls in the 5th grade 
in three areas of the country, but not in Cusco, the setting for 
this study. A qualitative study of decision-making processes 
among parents in Piura in northwestern Peru found that 
most parents accepted the new vaccine, but some parents 
expressed an overall lack of confidence in the health sys-
tem, which reduced their enthusiasm.11,12 HPV vaccination 
coverage rates for Peru are only available as estimates from 
demonstration projects in circumscribed areas; however, 
the 2014 estimate for the full course of HPV vaccination for 
girls between 10 and 14 years in South America is 40%.13 
This overall percentage overestimates coverage in Peru since 
there have been stronger HPV vaccination programs in other 
South American countries, like Argentina, where rates for 
full course coverage have been estimated at 52%.14
setting
CerviCusco, a Peruvian registered nongovernmental organiza-
tion (NGO) located in Cusco, is committed to improving the 
health and quality of life of Peruvian women through the pri-
mary and secondary prevention of cervical cancer.15 In addi-
tion to providing low-cost, clinic-based services since 2008, 
CerviCusco also conducts free medical outreach campaigns 
to provide access to care for those women who are unable to 
travel to Cusco. CerviCusco collaborates with MINSA, aca-
demia, private health care systems, local health care provid-
ers, medical device companies, and the community to foster 
community acceptance and ensure program sustainability for 
these campaigns. CerviCusco is the only health facility in 
the mountain region of Peru to offer liquid-based cytology, 
wherein samples are transferred to vials for analysis.




cervical cancer screening campaigns in Peru
CerviCusco currently provides cervical cancer screening 
to over 10,000 women annually. It screened 9,998 patients in 
2014 and 13,397 patients in 2015 with the liquid-based Pap 
test. Of the patients screened in 2014, 1,386 (14%) patients 
had abnormal results and 444 received further diagnosis 
using colposcopy. In 2014, 134 Cono loop electrosurgical 
excision procedure (LEEP) procedures were conducted, and 
there were 9 confirmed cases of invasive cervical cancer. In 
2015, there were 11 confirmed cervical cancer cases.
This descriptive, mixed method case study conducted in 
Cusco, Peru, aimed to assess the attitudes and perceptions of 
medical staff (doctors, nurses, and nurse midwives), health 
care workers, and patients toward both clinical services and 
outreach screening campaigns delivered by CerviCusco. The 
purpose of conducting these key informant interviews was to 
characterize these attitudes and perceptions to provide feed-
back to CerviCusco leadership in order to improve quality and 
monitor dissemination of evidence-based clinical practice. 
This study primarily interviewed key informants who either 
worked directly for CerviCusco or worked for the MINSA 
and collaborated with CerviCusco to gather in-depth, con-
fidential opinions. The study also explored knowledge, atti-
tudes, and beliefs of cervical cancer of CerviCusco patients 
and collected information about their opinions of CerviCusco 
services. The results of the study findings contributed to the 
improvement of the quality of services and prompted the 
development of culturally and linguistically appropriate edu-
cational and promotional materials to improve the educational 
component of the outreach campaigns.
Methods
This study employed qualitative interviews with key infor-
mants and surveys with patients. All research participants 
completed a written informed consent process prior to being 
interviewed or surveyed. The study was approved by the 
institutional review boards of the National Institute of Health 
of the Peruvian Government (INS), Augusta University, and 
Georgia Southern University.
Medical staff informant interviews
In spring 2014, the study team employed a structured instru-
ment (interview guide composed of 12 open-ended questions) 
to interview the medical staff and health care workers in 
Cusco and health care workers and government officials in a 
small rural community (district of Quiquijana in Quispicanchi 
Province) where a recent outreach campaign had taken place. 
All medical staff and health care workers who were inter-
viewed were either employed by CerviCusco or worked as 
nurse-midwives or doctors in the health department and were 
delivering screening samples to be analyzed. The purpose 
of the interviews was to collect information on major health 
problems in the Cusco region; community attitudes toward 
health, prevention, and health services; community and health 
care personnel attitudes toward CerviCusco services; and 
identify recommendations to address any problems identified 
with CerviCusco clinical operations. Participants included 
eight medical staff and health care workers from CerviCusco 
(which included nurses, nurse-midwives, administrative staff, 
a doctor, and a laboratory cytotechnologist), two from the 
Quiquijana government social welfare office, and six nurse-
midwives or doctors from MINSA in Cusco (including 1 
from Quiquijana). The interviews were conducted in Spanish, 
recorded and transcribed, and analyzed by question for 
themes using MAXQDA 11 (Marburg, Germany). Quotes 
and response summaries illustrate key themes.
Patient survey
To explore patient data related to cervical cancer, surveys 
were administered to CerviCusco patients incorporating both 
open-ended and close-ended questions after they received a 
cervical cancer screening examination either in CerviCusco 
or at an outreach campaign. The open-ended questions 
covered topics including community health resources and 
attitudes toward CerviCusco services; beliefs and attitudes 
about common health conditions, prevention, causes, and 
treatments; patients’ health history; and cancer knowledge. 
For close-ended questions, participants answered questions 
about their knowledge and beliefs about HPV/cervical cancer 
drawn from the Spanish language version of the National 
Cancer Institute’s Health Information National Trends 
Survey.16 Participants also responded to agree/disagree ques-
tions on attitudes and beliefs toward cervical cancer that had 
been used in a previous survey with Latina immigrant women 
in the US.17 In addition, patients reported demographic infor-
mation including age, years of formal education, marital sta-
tus, weekly income, family size, and language acculturation 
measured on a 4-point language acculturation scale.18
From March to June 2014, the study team administered 
30 surveys to a convenience sample of women aged 30–49 years 
who had just received a Pap test from CerviCusco. Surveys 
took ~45 min to administer. Ten surveys were completed 
in the CerviCusco clinic, and 20 surveys were completed 
during screening outreach campaigns in four rural areas 
where campaigns were being held (Chinchaypucyo, Anta 
Province; Calca, Calca Province; Maras, Urubamba Province; 
and Urcos, Quispicanchi Province). Descriptive statistics 





(means/ranges and numbers/percentages) were calculated. 
Open-ended questions were summarized for most frequent 
responses and then categorized.
Results
Key informant interviews – medical staff 
and health care workers
Participant demographics
Of the 16 participants, 14 were female and 2 were male. Half 
of the participants worked directly for CerviCusco, and the 
other half of the participants were collaborators with Cervi-
Cusco but worked for government agencies. Key informant 
demographic characteristics are summarized in Table 1.
cervicusco procedures for screening and follow-up
CerviCusco medical staff reported that any patients with 
atypical results (eg, ASCUS, LSIL, and HSIL) were called 
for follow-up and received a colposcopy examination if 
necessary for further diagnosis. Patients with abnormal 
results attending outreach campaigns were told to return 
to their local MINSA office after 1 month to receive their 
results. In the case of abnormal results, they were scheduled 
for follow-up at CerviCusco. The clinic also performed 
follow-up diagnostics with biopsies. With the more serious 
cases requiring radiotherapy and chemotherapy, patients were 
usually referred to the Instituto Nacional de Enfermedades 
Neoplásticas (National Cancer Institute) in Lima. Cone 
biopsies or LEEP could be done in CerviCusco only when 
the visiting physician was present, which was approximately 
during a 1-week period every other month. Because of the 
poor economic situation of many patients, seeking treatment 
in distant Lima was not a realistic option.
Personal experiences with cervical cancer patients
Participants were asked to share brief vignettes about patients 
they knew who had cancer. The themes throughout these 
stories emphasized late diagnoses and financial constraints to 
secure treatment. Because of the high rates of cervical cancer 
in Peru, one doctor reported that many unnecessary cone biop-
sies were being done on healthy women in their 20s at one of 
the regional hospitals. However, there were some rare cases 
discussed of women in their 20s and 30s who had advanced 
cervical cancer. Other patients were able to receive simple 
hysterectomies in Cusco at a public or regional hospital.
Perceived community attitudes toward health care
The majority of medical staff participants felt that the general 
public had a very negative view of government health services. 
They attributed these perceptions to patient complaints of: 
1) long wait times; 2) difficulty in getting referrals to a specialist; 
3) not receiving test results in a timely manner (or ever) – up 
to 6 months for Pap test results was reported by one doctor; 4) 
lack of caring attitudes from health care workers; 5) having to 
pay more for a private clinic because of inefficiencies in the 
government system; and 6) having to fill out a lot of paperwork 
for free or low-cost services. These issues were also recognized 
by medical staff and government officials themselves. One 
Quiquijana government official stated that medical services 
were suboptimal because of “tight government budgets, poor 
remuneration of health care personnel, and a shortage of medi-
cines.” There was reportedly poor infrastructure and mainte-
nance of facilities in the region. One doctor explained that in 
the Social Security hospital, oftentimes women would have 
trouble scheduling their appointments because “there are 
very few gynecologists in Cusco” or they would miss their 
appointments because of “other priorities.” She indicated that 
in her private practice, many women in their 40s and 50s had 
never had a Pap test, thus explaining the high rates of cervical 
cancer. This doctor noted cultural factors and commented on 
a common conversation with her patients,
Why don’t you go to the health center to get a Pap test? 
But the Quechua speaking patient, patient in the rural area, 
doesn’t like her genitals to be touched.
One theme running throughout the interviews was the 
perception that the general population lacked a culture of 
Table 1 Demographic characteristics of interview participants
Characteristic Total (N=16)
Age, years 37 (27–63)
Years of schooling 18 (16–27)





Administrative or other 5 (31%)
Affiliation
cervicusco 8 (50%)
MinsA or other government agency 8 (50%)
Marital status






Notes: Data are presented as mean values (ranges) for continuous variables and fre-
quencies (percentages) for categorical variables. *1 Peruvian nuevo sol =0.30 UsD.
Abbreviation: MinsA, Peru Ministry of health.
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preventive health care and would “wait until symptoms were 
severe before seeking treatment.” Participants stated that 
many patients had little education about their health. For 
example, one nurse-midwife in a rural community stated,
there are many cases of cancer in women, because there is 
little prevention, and there is a lack of knowledge about the 
importance of the Pap test.
Another nurse-midwife who worked in a mobile unit 
explained that she was constantly “fighting” with women to 
have them get their Pap. The CerviCusco staff indicated that 
Quechua women showed the most resistance and that they 
were not aware of the risk factors or symptoms of cervical 
cancer. According to the medical staff, Quechua women 
held many ethnomedical beliefs about the earth, that one 
can contract illnesses from the wind, and with a “cleansing” 
from a curandero, or natural healer, one would get better. 
In addition, cultural attitudes such as machismo and prob-
lems like alcoholism, which contributed to domestic abuse, 
were issues that impeded medical care for women. Report-
edly, many women of low education backgrounds did not 
want to see a male doctor for gynecological examinations, 
because of past experiences of spousal abuse and control-
ling husbands. One male nurse-midwife reported that he did 
not feel his gender affected his ability to perform Pap tests; 
however, there was a language barrier because he did not 
speak Quechua and the patients were very reserved about 
exposing their genitalia. Finally, key informants indicated 
that some people had low access to health care because of 
geographical barriers (rurality).
Attitudes toward cervicusco services
Overall, all the health care worker participants indicated 
their patients were very much satisfied with the services they 
received at CerviCusco. A nurse-midwife from the public 
sector remembered that before CerviCusco, Pap tests were 
sent to one of two hospitals, but now the tests were sent 
directly to CerviCusco. He was pleased that results were 
received much faster now, that is, in 10 days. He indicated 
that the view of his practice had improved because the 
services were free or low cost.
The main problem CerviCusco staff reported was vari-
ability in turnaround for liquid Pap test results. Sometimes 
results were timely in 2–3 days, but occasionally they could 
be delayed for a few weeks because of an excessive workload. 
To receive their results, patients would either have to call 
or return to CerviCusco. For women who received Pap tests 
in the campaigns, they would have to return to the health 
department that collaborated with CerviCusco to receive 
their results after 1 month. In Quiquijana, the women did not 
receive written results but only received the results verbally 
from the nurse-midwife who maintained the patient charts.
The majority of the CerviCusco staff suggested that the 
clinic could improve patient volume by having a site or a 
satellite office more centrally located in Cusco, having only 
morning operating hours like other clinics – which has now 
been implemented – and improving the marketing of the clinic 
rather than just relying on word-of-mouth. One of the doctors 
collaborating with CerviCusco also suggested the need for 
more equipment and services at CerviCusco, such as urinary 
and blood laboratory examination equipment, X-ray, cobalt 
therapy, and a pharmacy. None of these facilities were in the 
same neighborhood as CerviCusco, which is located about 
20 min from the city center, thus presenting patients with 
additional follow-up challenges to address their health con-
ditions depending on where they lived. For cancer patients, 
the problem was that there were no radiotherapy services in 
Cusco, and patients would have to wait for 2–3 months to 
receive these services in Lima or Arequipa.
Patient survey
Participant demographics
Table 2 describes the demographics of the 30 survey par-
ticipants. The average age of the participants was 40 years, 
with an average of 6.5 years of formal schooling. The women 
Table 2 Demographic characteristics of survey participants
Characteristic Total (N=30)
Age, years 40 (30–49)
Years of schooling 6.5 (0–18)
number of people in household 4 (2–7)
Median income category/week (soles) 201–400*
score on language acculturation scale  






Married/living with a partner 16 (87%)
single/other 4 (13%)
currently employed 20 (67%)
regular health care provider 9 (30%)





Notes: *1 Peruvian nuevo sol =0.30 UsD. Data are presented as mean values 
(ranges) for continuous variables, and frequencies (percentages) for categorical 
variables. aModified version of the Acculturation Scale for Mexican Americans was 
used to measure acculturation (substituting “Quechua” for “english” language).18





were mostly Quechua-dominant speakers (21; 70%) based 
on the low acculturation score for Spanish language (0.7) on 
the 4-point language acculturation scale. The median weekly 
income range was 201–400 soles (74–148 USD).
community health resources and attitudes toward 
the campaigns
The first part of the survey included open-ended questions 
about health topics. When asked about health resources in the 
community, participants most frequently mentioned health 
centers and curanderos. Other resources listed included 
nurse-midwives, private clinics, and regional hospitals. 
Participants were asked to comment on the services they 
received at CerviCusco. The clinic patients had to pay for 
services, unlike those who received free services at the 
CerviCusco outreach campaigns. The clinic patients said 
that the prices were reasonable and more affordable than the 
private clinics. Patients attending the campaigns liked that 
the services were free and of good quality. Critical comments 
included having to wait in queue, not being able to com-
municate in Quechua with health care staff, lack of Spanish 
skills among the American doctors, and not having additional 
free health services, such as physical examination or blood 
sugar testing. CerviCusco has two nurse-midwives who are 
bilingual in Quechua and Spanish, and the Spanish-speaking 
CerviCusco doctor speaks basic Quechua. Sometimes health 
care professional volunteers from the US would assist with 
the outreach campaigns, so patients would require translators. 
Since the surveys were taken at the time of screening, some 
participants expressed the hope that the results would arrive 
promptly, since results could potentially be delayed based 
on their past experiences with health care.
general health conditions and health services
Participants responded to a question about where they nor-
mally received health services. Most women answered that 
they received services at the health department (centro or 
puesto de salud). Two participants indicated that they would 
first use home remedies or a curandero before going to the 
health center. The type of services they received at a health 
center or a private clinic included medical, dental, nursing, 
obstetrics, lab, colposcopy, injections, family planning, psy-
chology, and pediatrics. Only nine (30%) women reported 
that they had a regular health care provider, such as a doctor 
at the health department or a private clinic.
Prevention and cervical cancer knowledge
When asked what tactic one can use to prevent disease, the 
most common response was to wear warm clothes and drink 
hot tea. Other preventive measures that they mentioned 
included not taking antibiotics, personal hygiene, avoiding 
fast food and street vendors, eating fruits and vegetables, 
taking vitamins, and getting regular check-ups. Several 
women mentioned good hygiene, receiving regular medical 
checks, and limiting the number of sexual partners as methods 
to prevent cancer. Regarding prevention of cervical cancer, 
women most commonly listed getting a yearly Pap test. 
Other methods included limiting number of sexual partners, 
washing private areas with herbs, not having an abortion, 
and good hygiene.
Nine (30%) participants said they had never heard of 
cervical cancer. Of those who had heard of it, most said they 
had heard about it in the health department, but some also 
said they had heard of it from a friend or in the media. Most 
participants answered that they did not know what treatments 
existed for cancer; however, some responses included, “it 
is incurable, there is no treatment,” and “taking different 
medicines.” Some participants also responded, “there is no 
cure when it is advanced,” “if a woman doesn’t have money 
to get treatment, she will die,” and “when someone has 
cancer, it is not possible to get better.” Participants were also 
asked whether they knew anyone who had ever told them that 
she had cervical cancer. Eight (27%) women reported that 
they had a friend or someone they knew who had told them 
they had cervical cancer.
Pap test history and hPV knowledge
Since the patient surveys were administered after women 
had just been screened, all participants surveyed had recently 
received a Pap test. Twenty-four (80%) women reported 
that a health care provider had recommended a Pap test. 
Most women reported receiving their Pap tests in the cam-
paigns or at the health department. Table 3 summarizes the 
participants’ health history, cervical cancer screening, and 
HPV knowledge. When asked how long before their most 
recent Pap test did they receive the previous one, 10 (33%) 
women reported in the last year, 8 (27%) in the last 2 years, 
5 (17%) in the last 3 years, 3 (10%) women over 3 years 
ago, and the rest (13%) had never received a Pap test before. 
The female participants were asked whether they had any 
concerns about the Pap test. Those who expressed concerns 
listed a number of reasons including: fearing that tubal 
ligation could cause cancer or an infection, having vaginal 
secretions, and fearing that ulcers that could be cancer. 
Women were asked how often they should have a Pap test. 
Sixteen (53%) participants reported 1 year or less, 5 (17%) 
participants listed between 1 and 3 years, and the rest (9%) 
did not know.
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The survey also included a number of questions about 
HPV and the HPV vaccine. Only 6 (20%) women said they 
had heard of HPV. Of those who had heard of HPV, most 
said they had heard about it at the health department. Only 
2 women had been told by a doctor that they had a HPV 
infection. Five (17%) women had heard of the HPV vaccine. 
These participants listed that lack of knowledge, money, and 
fear of injection pain as potential reasons would keep some-
one from getting the vaccine. When asked what would moti-
vate women to get the vaccine, responses included education, 
low cost or free product, promotion, and good treatment of 
patients. Participants were also asked to agree or disagree 
with attitudes and beliefs about cervical cancer and screening. 
All participants agreed with the statement, “I would undergo 
cervical cancer treatment that is unpleasant or painful if it 
would increase my chances of living longer,” and 26 (87%) 
participants agreed with the statement, “if cervical cancer 
is found early, it can be cured.” Half of participants agreed 
that there was not much they could do to prevent cervical 
cancer, and 63% of the participants would rather not know 
if they actually had cervical cancer.
Discussion
In this study, both the key informants and the patients 
described individual and structural barriers to accessing 
cervical cancer screening services, follow-up, and treatment 
in the public health sector. Similar to a previous study, major 
problems identified with health services in Peru included 
lack of resources and difficulty in accessing cancer treat-
ment services, since they were centralized in either Lima 
or Arequipa.5 However, the same participants reported 
that superior services and timely follow-up were available 
from private and NGO clinics. CerviCusco is unique in the 
Cusco region since it functions as a stationary clinic and 
also provides mobile clinic outreach services. Although 
there were some challenges identified by patients in the 
screening outreach campaigns, such as waiting in queues and 
not having additional health services besides the Pap test, 
such as screening for other health conditions, there was an 
overwhelmingly positive response to the services received 
and confidence in the professionalism of the CerviCusco 
medical staff.
The efforts of CerviCusco to provide screening opportu-
nities through screening outreach campaigns addresses one 
of the primary barriers to women receiving timely screening 
(eg, poor access to health services). There is evidence from 
evaluations of other screening campaigns in Peru that both 
community promotional events and static screening facili-
ties are needed to increase screening participation.4,19,20 The 
convenience of accessing screening opportunities in both 
urban and rural areas around Cusco allowed community 
participants to receive services, many for the first time. 
As a previous study in Peru recommended, a national cam-
paign to educate the public and ensure regular screening 
and follow-up would be one effective means to increase 
screening coverage.5 Since Peru is similar to some other 
South American countries, like Colombia, Ecuador, and 
Bolivia, where cervical cancer screening is only available 
in certain regions, Peru would benefit from more cervical 
cancer screening outreach in other areas of Peru where 
screening is not easily accessible.21,22 To address structural 
barriers and screening access in Peru, different strategies have 
been employed to expand cervical cancer screening using 
low-cost methods such as VIA. Although there are inherent 
advantages to rapid diagnostic methods, such as VIA, these 
are offset by suboptimal diagnostic accuracy which can lead 
Table 3 health history, cervical cancer screening history, hPV 
knowledge, and cervical cancer attitudes and beliefs among survey 
participants
Survey item Total (N=30)
Pap test before the most recent Pap test was 
within the past 3 years
23 (77%)
expect to have another Pap test in the next year 21 (70%)
had received a provider’s recommendation for 
a Pap test
24 (80%)
had received family planning services 22 (73%)
had heard of hPV 6 (20%)
Thought hPV caused cervical cancer 6 (20%)
Thought hPV was sexually transmitted 8 (27%)
Thought hPV was common 4 (13%)
Thought hPV would go away on its own 
without treatment
5 (17%)
Thought hPV could cause abnormal Pap tests 5 (17%)
had heard of the hPV vaccine 5 (17%)
Thought the hPV vaccine was an effective way 
to prevent hPV infection
2 (7%)
if had hPV, would tell their partner? 22 (73%)
Thought if cervical cancer is found early, it can 
be cured
26 (87%)
i would undergo cervical cancer treatment that 
is unpleasant or painful if it would increase my 
chances of living longer
30 (100%)
i would rather not know if i had cervical cancer 19 (63%)
i would be afraid to tell my husband or partner 
if i had cervical cancer
11 (37%)
i need a Pap smear only when i experience 
vaginal bleeding other than menstruation 
(or when i experience other symptoms)
16 (53%)
There is not much i can do to prevent 
cervical cancer
15 (50%)
i am very likely to get cervical cancer sometime 
in my lifetime
12 (40%)
Note: Data are presented as frequencies (percentages) of participants who reported 
a characteristic or agreed with the statement.





to inappropriate treatment for many and undetected disease 
in others. This tension between physician preferences for 
VIA versus conventional Pap test was identified in a survey 
of Bolivian providers who believed VIA would be preferable 
to women because of their cultural preference for wanting 
rapid results and not trusting results that would not be ready 
for several weeks. However, professionally, there was a 
national program advocating Pap testing; hence, a significant 
minority of providers favored Pap test over VIA.23
To address poor access to quality health care for the 
indigenous population, CerviCusco has evaluated a program 
of temporary screening clinics held in public marketplaces 
frequented by the target population on a weekly basis.24 
Patients reported a preference for having their Pap test in 
market areas in tents since it was more convenient and 
accessible than going to the clinic. However, other bottle-
necks in the system remain, such as cost and transportation 
barriers to receive follow-up treatment for abnormal Pap 
test findings.19,25 Hence, multiple deficiencies in the current 
cancer prevention program in Peru exist. For middle-income 
countries, many challenges remain for implementing high-
quality Pap test programs.26 With newer options becoming 
available even in poor-resource countries, a new cervical 
cancer prevention model based on limited interval HPV 
testing and widespread HPV vaccination may offer hope 
for reducing the high rates of these preventable cancers.20,27
The key informant interviews suggested that radio is the 
principal medium for advertising health screening events, 
and the patient surveys indicated that most people own a 
radio. Yet, advertising adds additional expense to health 
care resources that are already challenged financially. Cer-
viCusco is currently working to expand its marketing and 
outreach efforts to boost patient volume in both the clinic 
and community setting by using social media and radio 
advertising. The clinic has also standardized their operating 
hours, and now they are open Monday through Saturday 
from 8 am to 2 pm. CerviCusco has experience with educat-
ing patients through culturally sensitive educational videos 
in the Quechua language to reduce anxiety about Pap and 
colposcopy examinations.28 An additional video describes 
the electrosurgery procedure in both Quechua and Spanish.29 
Building on these previous successes, the study team devel-
oped Spanish-language photonovellas and Quechua-language 
radio advertisements as part of an educational outreach 
strategy to increase knowledge about cervical cancer.30 
These materials are now being used to better inform patients 
about the purpose and benefits of cervical cancer screening. 
These efforts address the marketing deficiencies that were 
identified in the key informant interviews. Furthermore, 
CerviCusco hired a marketing professional to lead fundrais-
ing efforts and other promotional activities. In addition, a 
team from BD Pharmaceuticals and IBM, in partnership with 
Direct Relief, participated in volunteer service trips between 
2014 and 2016. Their efforts helped to expand laboratory 
facilities, improve laboratory design and infrastructure, 
implement an electronic medical record system, improve 
marketing, and develop engineering solutions to streamline 
clinic operations.31
Individual barriers to screening in Peru include having 
other priorities and fear of cancer as a death sentence.10 
In addition, low knowledge of HPV and cervical cancer 
makes the purpose of screening unclear.32 The low knowl-
edge of cervical cancer/HPV and low education levels 
among our patient participants may be associated with their 
fatalistic beliefs expressed in their responses to the questions 
about their chances of getting cervical cancer and interest in 
knowing about a hypothetical cervical cancer diagnosis. The 
current study found that only 20% of patients thought HPV 
was linked to cervical cancer. This is lower than a larger 
survey study completed in Lima in 2006 which found that 
38% knew of the link.33 While considering disease preven-
tion, ethnomedical beliefs and reducing exposures are the 
predominant concerns. The patient knowledge data from 
this study are similar to other studies in Peru which have 
found that there is limited knowledge and consensus about 
cervical cancer causes, screening, and treatment options.3,6 
The belief that cervical cancer was a deadly disease was 
reinforced by survey findings which found that half of par-
ticipants “did not think there was anything they could do to 
prevent cervical cancer.” In this study, screening was not 
necessarily viewed as a preventive practice, and there were 
negative consequences associated with screening. Lack of 
awareness of cervical cancer among this Quechua language 
dominant patient population could also be linked to low 
Spanish literacy since most posters and educational materials 
found in health departments are in Spanish.
This descriptive case study was an assessment of a 
particular nonprofit clinic; hence, the intent was not to gen-
eralize to other regions of Peru, but to assess one model for 
how a quality cervical cancer screening program might be 
instituted in a low resource country. The study only inter-
viewed key informants who either worked for or collabo-
rated directly with CerviCusco (except for the small sample 
from Quiquijana), thus some findings related to the quality 
of clinic services and patient satisfaction might have been 
positively biased. The survey was based on a small sample 
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size; hence, inferential statistics could not be used to analyze 
the factors associated with health care utilization among 
patients. The intent of the survey was to offer a snapshot of 
patient’s experiences with clinic services both at the station-
ary clinic and at the outreach campaigns.
Conclusion
The study findings that there was low knowledge of the pur-
pose of cervical cancer screening or the effective treatment 
available for the disease among patients led to the develop-
ment and dissemination of a photonovella to describe the 
process of cervical cancer screening at the campaigns. This 
pamphlet contributed to the educational component of the 
periodic campaigns conducted primarily in rural areas of 
Andean Peru to supplement the information received from 
the doctor or nurse-midwife during the Pap test. In addition, 
CerviCusco has recently expanded its cervical cancer preven-
tion services to include the HPV vaccine at no cost to patients. 
In 2016, they are administering 20,000 doses of the vaccine 
to eligible patients. CerviCusco has demonstrated its capac-
ity to provide screening outreach campaigns to populations 
who had not previously had access to liquid-based cytology 
services. CerviCusco reaches vulnerable populations in the 
rural highlands to help to reduce the coverage gap that exists 
in contemporary Peru.
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